New tentative approval for Watson Labs drug dienogest; estradiol valerate
February 8, 2019Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch - Make Better Decisions.
